Icon Advisers Inc. Co. bought a new stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,800 shares of the medical technology company’s stock, valued at approximately $429,000.

A number of other institutional investors also recently added to or reduced their stakes in HRC. Capstone Asset Management Co. grew its stake in shares of Hill-Rom by 2.4% in the 2nd quarter. Capstone Asset Management Co. now owns 7,695 shares of the medical technology company’s stock worth $613,000 after purchasing an additional 180 shares during the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of Hill-Rom by 4.6% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 21,882 shares of the medical technology company’s stock worth $1,742,000 after purchasing an additional 969 shares during the last quarter. LS Investment Advisors LLC grew its stake in shares of Hill-Rom by 19.4% in the 2nd quarter. LS Investment Advisors LLC now owns 5,012 shares of the medical technology company’s stock worth $399,000 after purchasing an additional 815 shares during the last quarter. Aperio Group LLC grew its stake in shares of Hill-Rom by 10.7% in the 2nd quarter. Aperio Group LLC now owns 21,484 shares of the medical technology company’s stock worth $1,710,000 after purchasing an additional 2,078 shares during the last quarter. Finally, State Treasurer State of Michigan grew its stake in shares of Hill-Rom by 2.1% in the 2nd quarter. State Treasurer State of Michigan now owns 24,650 shares of the medical technology company’s stock worth $1,962,000 after purchasing an additional 500 shares during the last quarter. 80.37% of the stock is currently owned by hedge funds and other institutional investors.

In other Hill-Rom news, SVP Andreas G. Frank sold 3,940 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total value of $306,689.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at $1,300,005.84. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Andreas G. Frank sold 6,870 shares of the firm’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

HRC has been the topic of several recent research reports. Needham & Company LLC lowered their price objective on shares of Hill-Rom from $93.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, November 6th. Barclays PLC lifted their price objective on shares of Hill-Rom from $86.00 to $90.00 and gave the stock an “overweight” rating in a research note on Monday, November 6th. ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. KeyCorp reaffirmed a “buy” rating and issued a $89.00 price objective (up previously from $82.00) on shares of Hill-Rom in a research note on Sunday, November 5th. Finally, Zacks Investment Research raised shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $90.00 price objective on the stock in a research note on Friday, October 27th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $88.57.

Hill-Rom Holdings Inc (NYSE HRC) opened at $83.53 on Friday. Hill-Rom Holdings Inc has a 52 week low of $52.58 and a 52 week high of $84.65. The stock has a market cap of $5,498.03, a P/E ratio of 21.64, a PEG ratio of 1.78 and a beta of 1.19. The company has a quick ratio of 1.34, a current ratio of 1.77 and a debt-to-equity ratio of 1.55.

Hill-Rom (NYSE:HRC) last announced its earnings results on Friday, November 3rd. The medical technology company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.27 by $0.05. Hill-Rom had a net margin of 4.87% and a return on equity of 20.27%. The company had revenue of $738.30 million during the quarter, compared to analysts’ expectations of $731.10 million. During the same period last year, the company posted $1.18 earnings per share. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. research analysts expect that Hill-Rom Holdings Inc will post 4.26 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, December 14th. Hill-Rom’s payout ratio is 36.18%.

COPYRIGHT VIOLATION NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/icon-advisers-inc-co-takes-position-in-hill-rom-holdings-inc-hrc/1727413.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.